Birendra Sah profile picture
315 464-3835

Birendra Sah, MD, FCCP

2604 Upstate University Hospital
750 East Adams Street
Syracuse, NY 13210
Birendra Sah's email address generated as an image

CURRENT APPOINTMENTS

Associate Professor of Medicine

SPECIALTIES

Internal Medicine
Pulmonary Diseases
Critical Care Medicine

LANGUAGES

English
Nepali
Hindi

PATIENT TYPE

Adults

RESEARCH INTERESTS

Sarcoidosis

 

ASSOCIATIONS / MEMBERSHIPS

American College of Chest Physicians (ACCP)
American Thoracic Society (ATS)
Society of Critical Care Medicine

EDUCATION

Fellowship: SUNY Upstate Medical University, 2011
Residency: SUNY Upstate Medical University, 2008
MD: B. P. Koirala Institute of Health Science, Dharan, Nepal, 2001

RESEARCH ABSTRACT

Epub 2015 Oct 23.

Novel pharmacotherapy of sarcoidosis

Birendra P Sah 1Shraddha Goyal 2Michael C Iannuzzi 2

 

PMID: 26478443   DOI: 10.1016/j.pharmthera.2015.10.001

 

Abstract

Sarcoidosis is a multisystem granulomatous disease of unknown etiology that most commonly affects the lungs. Treatment of sarcoidosis can be challenging as it is often difficult to measure disease activity and distinguish active inflammation from fibrosis. Identifying the inflammatory mediators in sarcoidosis has led to the development and use of novel therapeutic agents. The goal of pharmacotherapy is to decrease granuloma accumulation, ameliorate symptoms and improve organ function. Systemic corticosteroids remain the first line treatment. Other immunosuppressive agents may be considered for the patients who respond poorly to corticosteroids or who experience significant adverse effects. An overview of pharmacotherapy of sarcoidosis is provided here.

Keywords: Corticosteroids; Immunosuppressive agents; Pulmonary; Sarcoidosis; Symptoms; Treatment.

 

PUBLICATIONS

Link to PubMed (Opens new window. Close the PubMed window to return to this page.)